Method for producing substituted anthranilic acid derivatives

US9670182B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9670182-B2
Application numberUS-201514924889-A
CountryUS
Kind codeB2
Filing dateOct 28, 2015
Priority dateFeb 7, 2012
Publication dateJun 6, 2017
Grant dateJun 6, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a process for preparing substituted anthranilic acid derivatives of the formula (I) in which R 1 , R 2 , R 3 and R 4 are each as defined in the description, by conversion of compounds of the general formula (IV) in the presence of a palladium catalyst and carbon monoxide. The present invention likewise relates to compounds of the general formula (IV).

First claim

Opening claim text (preview).

The invention claimed is: 1. Process for preparing a compound of formula (I) in which R 1 is a hetaryl radical of formula (II) where R 8 is C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulphinyl, C 1 -C 4 -alkylsulphonyl, which may optionally be mono- or polysubstituted, identically or differently by fluorine or chlorine, or is fluorine, chlorine, cyano, alkylamino, dialkylamino, cycloalkylamino or C 3 -C 6 -trialkylsilyl, Z is CH or N, and Y is hydrogen, fluorine, chlorine, optionally singly or multiply, identically or differently fluorine- or chlorine-substituted C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulphinyl, C 1 -C 4 -alkylsulphonyl, or is cyano, alkylamino, dialkylamino, cycloalkylamino, C 3 -C 6 -trialkylsilyl or a radical of formula (III) where R 9 is C 1 -C 5 -alkyl which may optionally be mono- or polysubstituted identically or differently by halogen, R 2 is an OR 5 or NR 6 R 7 radical, where R 5 , R 6 and R 7 are each independently hydrogen, C 1 -C 6 -alkyl, or C 6 -C 10 -aryl, R 3 is optionally singly or multiply, identically or differently fluorine- or chlorine-substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy or C 3 -C 6 -cycloalkyl, R 4 is hydrogen, fluorine, chlorine, cyano, optionally singly or multiply, identically or differently fluorine- or chlorine-substituted C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulphinyl, C 1 -C 4 -alkylsulphonyl, C 1 -C 4 -alkylamino, di(C 1 -C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino, (C 1 -C 4 -alkoxy)imino, (C 1 -C 4 -alkyl)(C 1 -C 4 -alkoxy)imino, SF 5 or C 3 -C 6 -trialkylsilyl, comprising reacting a substituted anthranilamide derivative of the formula (IV) in which the R 1 , R 3 and R 4 radicals are each as defined above and X is chlorine, bromine or iodine, in the presence of a palladium catalyst and optionally of a phosphine ligand simultaneously with carbon monoxide and a compound of formula (V) R 5 —OH  (V) in which R 5 is as defined above or a compound of formula (VI) HNR 6 R 7   (VI) in which R 6 and R 7 are each as defined above, wherein the compound of formula (IV) is prepared by reacting a compound of formula (IX) in which X, R 3 and R 4 are each as defined above with an acid of formula (VIII) R 1 COOH  (VIII) in which R 1 is as defined above. 2. Process according to claim 1 , wherein the compound of formula (IV) is prepared in the presence of a condensing agent and of a base. 3. Process according to claim 1 , wherein the palladium catalyst used is a palladium(II) salt and/or Pd(0) species. 4. Process according to claim 3 , wherein the palladium catalyst used is bis(dibenzylideneacetone)palladium, tris(dibenzylideneacetone)dipalladium, palladium chloride, palladium bromide and/or palladium acetate. 5. Process according to claim 1 , wherein the phosphine ligand is used and is a compound of formula (X) PR 10 R 11 R 12   (X) where the R 10 , R 11 and R 12 radicals are each independently hydrogen, linear or branched C 1 -C 8 -alkyl, vinyl, aryl or heteroaryl selected from pyridine, pyrimidine, pyrrole, thiophene and furan, which may in turn be substituted by further substituents from the group of linear or branched C 1 -C 8 -alkyl or C 6 -C 10 -aryl, linear or branched C 1 -C 8 -alkyloxy or C 1 -C 10 -aryloxy, halogenated linear or branched C 1 -C 8 -alkyl or halogenated C 6 -C 10 -aryl, C 6 -C 10 -aryloxycarbonyl, linear or branched C 1 -C 8 -alkylamino, linear or branched C 1 -C 8 -dialkylamino, C 1 -C 8 -arylamino, C 1 -C 8 -diarylamino, hydroxyl, carboxyl, cyano and halogen, or a chelating biphosphine. 6. Process according to claim 5 , wherein the chelating biphosphine is used and is one or more selected from 1,2-bis(diphenylphosphino)ethane, 1,2-bis(diphenylphosphino)propane, 1,2-bis(diphenylphosphino)butane, 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl and 1,1′-bis(diphenylphosphino)ferrocene. 7. Process according to claim 5 , wherein the phosphine ligand used is triphenylphosphine. 8. Process according to claim 5 , wherein 1-20 molar equivalents of phosphine are used, based on the amount of palladium catalyst used. 9. Process according to claim 1 , wherein R 2 is an OR 5 radical. 10. Process according to claim 1 , wherein R 2 is an NR 6 R 7 radical. 11. Process according to claim 1 , wherein R 3 is singly or multiply, identically or differently fluorine- or chlorine-substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy or C 3 -C 6 -cycloalkyl. 12. Process according to claim 1 , wherein R 4 is fluorine, chlorine, cyano, optionally singly or multiply, identically or differently fluorine- or chlorine-substituted C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylthio, C 1 -C 4 -alkylsulphinyl, C 1 -C 4 -alkylsulphonyl, C 1 -C 4 -alkylamino, di(C 1 -C 4 -alkyl)amino, C 3 -C 6 -cycloalkylamino, (C 1 -C 4 -alkoxy)imino, (C 1 -C 4 -alkyl)(C 1 -C 4 -alkoxy)imino, SF 5 or C 3 -C 6 -trialkylsilyl. 13. Process according to claim 1 , wherein a phosphine ligand is used. 14. Process according to claim 1 , wherein a compound of formula (V) is used. 15. Process according to claim 1 , wherein a compound of formula (VI) is used.

Assignees

Inventors

Classifications

  • by reactions not involving the formation of cyano groups · CPC title

  • at least one of the singly-bound nitrogen atoms being acylated · CPC title

  • C07D401/14Primary

    containing three or more hetero rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9670182B2 cover?
The present invention relates to a process for preparing substituted anthranilic acid derivatives of the formula (I) in which R 1 , R 2 , R 3 and R 4 are each as defined in the description, by conversion of compounds of the general formula (IV) in the presence of a palladium catalyst and carbon monoxide. The present invention likewise relates to compounds of the gen…
Who is the assignee on this patent?
Bayer Ip Gmbh
What technology area does this patent fall under?
Primary CPC classification C07D401/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).